Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-08-25

FDA Approved: RISPERIDONE — Supplemental Application (Westminster Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved Westminster Pharmaceuticals' supplemental application for risperidone, authorizing a generic version of the antipsychotic. The approval indicates t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RISPERIDONE (RISPERIDONE)

Snippet

SUPPL AP for RISPERIDONE (RISPERIDONE)